Asset profile
Toripalimab
Monoclonal antibody
Approvedregulatory verdict
Evidence outlook
Approved: Nasopharyngeal Carcinoma
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
Also in development:Non-Small Cell Lung Cancer · Phase 3
Featured evidence outside covered markets:TORCHLIGHT (NCT04085276) · Triple-Negative Breast Cancer · Phase 3 · met primary endpoint · Reliable signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
83 competitors in this universe: 22 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Toripalimab: this drug | Approved | Monoclonal antibody | PD-1 | ||
| Cemiplimab | Approved | Monoclonal antibody | PD-1 | ||
| Nivolumab | Approved | Monoclonal antibody | PD-1 | ||
| Opdivo Qvantig | Approved | Monoclonal antibody | PD-1 | ||
| Pembrolizumab | Approved | Monoclonal antibody | PD-1 | ||
| Pembrolizumab Berahyaluronidase Alfa | Approved | Monoclonal antibody | PD-1 | ||
| Retifanlimab | Approved | Monoclonal antibody | PD-1 | ||
| Abp 234 | Phase 3 | Monoclonal antibody | PD-1 | ||
| Balstilimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Camrelizumab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Cetrelimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| CT-P51 | Phase 3 | Small molecule | PD-1 | ||
| Dostarlimab | Phase 3 | Monoclonal antibody | PD-1 | ||
| Enlonstobart | Phase 3 | Monoclonal antibody | PD-1 | ||
| MB12 | Phase 3 | Monoclonal antibody | PD-1 | ||
| Penpulimab | Phase 3 | Monoclonal antibody | PD-1 |
…and 68 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
vs Cemiplimab · Non-Small Cell Lung Cancervs Nivolumab · Non-Small Cell Lung Cancervs Pembrolizumab · Non-Small Cell Lung Cancervs Retifanlimab · Non-Small Cell Lung Cancervs Camrelizumab · Non-Small Cell Lung Cancervs Dostarlimab · Non-Small Cell Lung Cancer
16 further head-to-head pairs are tracked; the rosters on each shared mechanism and indication page list every rival in the race.
Upcoming events
(201 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (27)
October 2026 (2)
Phase 2Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous ImmunotherapyNot yet recruiting
Est. primary completion 2026-10-30 · NCT06730932 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorActive not recruiting
Est. primary completion 2026-10-31 · NCT05518045 · CT.gov ↗
What to watch
November 2026 (2)
December 2026 (23)
Phase 1Pancreatic Neoplasms, Other Solid TumorsRecruiting
Est. primary completion 2026-12 · NCT06577532 · CT.gov ↗
What to watch
Phase 2Cervical CancersActive not recruiting
Est. primary completion 2026-12 · NCT06416696 · CT.gov ↗
What to watch
Phase 2Microsatellite Stable Metastatic Colorectal CancerRecruiting
Est. primary completion 2026-12 · NCT06525428 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2026-12 · NCT06323239 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2026-12 · NCT06654947 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2026-12 · NCT05340491 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-01 · NCT06426511 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Solid TumorsActive not recruiting
Est. primary completion 2026-12-15 · NCT06571422 · CT.gov ↗
What to watch
Phase 1/2Solid Tumor, AdultRecruiting
Est. primary completion 2026-12-30 · NCT06088004 · CT.gov ↗
What to watch
Phase 2Renal Insufficiency, Upper Urinary Tract Urothelial Carcinoma, Solitary KidneyRecruiting
Est. primary completion 2026-12-30 · NCT06354231 · CT.gov ↗
What to watch
Phase 2Non-clear Renal Cell CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT05768464 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-30 · NCT04772287 · CT.gov ↗
What to watch
Phase 1/2Advanced Urothelial CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06079112 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-31 · NCT05798845 · CT.gov ↗
What to watch
Phase 2Stomach NeoplasmsRecruiting
Est. primary completion 2026-12-31 · NCT05033392 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer, Hilar Cholangiocarcinoma, Distal CholangiocarcinomaActive not recruiting
Est. primary completion 2026-12-31 · NCT06717464 · CT.gov ↗
What to watch
Phase 2Locally Advanced Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06187597 · CT.gov ↗
What to watch
Phase 2Ovarian CancerRecruiting
Est. primary completion 2026-12-31 · NCT04918186 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2026-12-31 · NCT03859128 · CT.gov ↗
What to watch
Phase 3Advanced Hepatocellular Carcinoma (HCC)Active not recruiting
Est. primary completion 2026-12-31 · NCT04523493 · CT.gov ↗
What to watch
Phase 3Urothelial Carcinoma, HER2-expressingRecruiting
Est. primary completion 2026-12-31 · NCT05302284 · CT.gov ↗
What to watch
Early phase / not applicableEsophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2026-12-31 · NCT07067450 · CT.gov ↗
What to watch
2027 (81)
January 2027 (8)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-01 · NCT07493980 · CT.gov ↗
What to watch
Phase 2Paget Disease, Extramammary, Scrotum DiseaseRecruiting
Est. primary completion 2027-01 · NCT06791070 · CT.gov ↗
What to watch
Phase 1Hepatocellular Carcinoma (HCC)Enrolling by invitation
Est. primary completion 2027-01-01 · NCT06882876 · CT.gov ↗
What to watch
Phase 2Advanced Urothelial Carcinoma, Probiotics, ImmunotherapyRecruiting
Est. primary completion 2027-01-01 · NCT06904573 · CT.gov ↗
What to watch
Phase 1/2Malignant TumorsRecruiting
Est. primary completion 2027-01-11 · NCT05615974 · CT.gov ↗
What to watch
Phase 2Soft Tissue SarcomaRecruiting
Est. primary completion 2027-01-30 · NCT04589741 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-01-31 · NCT06269211 · CT.gov ↗
What to watch
Phase 2Limited Stage Small Cell Lung CancerRecruiting
Est. primary completion 2027-01-31 · NCT06256237 · CT.gov ↗
What to watch
February 2027 (4)
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-02-26 · NCT06208410 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-02-28 · NCT07438600 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-28 · NCT06623136 · CT.gov ↗
What to watch
Phase 2Radiation Therapy, Targeted Therapy, Immunotherapy, Renal Cancer MetastaticRecruiting
Est. primary completion 2027-02-28 · NCT06889649 · CT.gov ↗
What to watch
March 2027 (4)
Phase 3HR+/HER2- Breast CancerRecruiting
Est. primary completion 2027-03-23 · NCT06977893 · CT.gov ↗
What to watch
Phase 1/2Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2027-03-28 · NCT07320963 · CT.gov ↗
What to watch
Phase 1Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin NeoplasmActive not recruiting
Est. primary completion 2027-03-31 · NCT04387084 · CT.gov ↗
What to watch
Phase 3Gastric or Esophagogastric Junction AdenocarcinomaActive not recruiting
Est. primary completion 2027-03-31 · NCT05180734 · CT.gov ↗
What to watch
April 2027 (2)
Phase 2Muscle-Invasive Bladder Cancer (MIBC)Recruiting
Est. primary completion 2027-04 · NCT07647289 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H), Neoadjuvant TherapyRecruiting
Est. primary completion 2027-04-01 · NCT03926338 · CT.gov ↗
What to watch
May 2027 (5)
Phase 2Biliary Tract Cancer (BTC)Not yet recruiting
Est. primary completion 2027-05-01 · NCT06919848 · CT.gov ↗
What to watch
Phase 3Resectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-05-12 · NCT04848753 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2027-05-30 · NCT07040228 · CT.gov ↗
What to watch
Phase 2Biliary Tract Cancer, Disitamab Vedotin, Lenvatinib, Immune Checkpoint InhibitorsNot yet recruiting
Est. primary completion 2027-05-31 · NCT07159217 · CT.gov ↗
What to watch
Phase 3Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-05-31 · NCT05342194 · CT.gov ↗
What to watch
June 2027 (9)
Phase 2Triple Negative Breast NeoplasmsNot yet recruiting
Est. primary completion 2027-06 · NCT07040644 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06 · NCT06851247 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06437977 · CT.gov ↗
What to watch
Phase 2Penile CancerRecruiting
Est. primary completion 2027-06-01 · NCT06415318 · CT.gov ↗
What to watch
Phase 1/2Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol, SOX Chemotherapy, ToripalimabNot yet recruiting
Est. primary completion 2027-06-30 · NCT07727993 · CT.gov ↗
What to watch
Phase 2Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast CancerRecruiting
Est. primary completion 2027-06-30 · NCT06878625 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT06502080 · CT.gov ↗
What to watch
Phase 2Advanced Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-06-30 · NCT07484724 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06-30 · NCT06235203 · CT.gov ↗
What to watch
July 2027 (2)
August 2027 (6)
Phase 2Advanced Breast CancerRecruiting
Est. primary completion 2027-08 · NCT07540533 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumoursRecruiting
Est. primary completion 2027-08-01 · NCT06868199 · CT.gov ↗
What to watch
Phase 2Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-08-01 · NCT07088211 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant TherapyNot yet recruiting
Est. primary completion 2027-08-01 · NCT07720921 · CT.gov ↗
What to watch
Phase 2Locally Advanced Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-08-01 · NCT06843889 · CT.gov ↗
What to watch
Phase 2UrologyNot yet recruiting
Est. primary completion 2027-08-30 · NCT07151560 · CT.gov ↗
What to watch
September 2027 (5)
Phase 2Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2027-09 · NCT05484375 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaActive not recruiting
Est. primary completion 2027-09 · NCT06679985 · CT.gov ↗
What to watch
Phase 3Urothelial CarcinomaRecruiting
Est. primary completion 2027-09 · NCT06592326 · CT.gov ↗
What to watch
Phase 2Head and Neck CancerRecruiting
Est. primary completion 2027-09-01 · NCT06208826 · CT.gov ↗
What to watch
Phase 2Larynx Cancer, Hypopharyngeal CancerRecruiting
Est. primary completion 2027-09-01 · NCT06039631 · CT.gov ↗
What to watch
October 2027 (3)
Phase 2Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07189793 · CT.gov ↗
What to watch
Phase 1/2Advanced MelanomaRecruiting
Est. primary completion 2027-10-30 · NCT07099430 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaActive not recruiting
Est. primary completion 2027-10-31 · NCT06378177 · CT.gov ↗
What to watch
November 2027 (5)
Phase 2Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3Not yet recruiting
Est. primary completion 2027-11 · NCT05479045 · CT.gov ↗
What to watch
Phase 2TNBC - Triple-Negative Breast CancerNot yet recruiting
Est. primary completion 2027-11-30 · NCT07101614 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, MetastaticNot yet recruiting
Est. primary completion 2027-11-30 · NCT06283121 · CT.gov ↗
What to watch
Phase 2Advanced Malignant Solid TumorsRecruiting
Est. primary completion 2027-11-30 · NCT07480733 · CT.gov ↗
What to watch
Phase 2Advanced Lung CancerRecruiting
Est. primary completion 2027-11-30 · NCT07309276 · CT.gov ↗
What to watch
December 2027 (28)
Phase 2Extensive Stage Lung Small Cell CancerNot yet recruiting
Est. primary completion 2027-12 · NCT07172412 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2027-12 · NCT07481058 · CT.gov ↗
What to watch
Phase 2Carcinoma, Upper Tract Urothelial Carcinoma, UTUCRecruiting
Est. primary completion 2027-12 · NCT05917158 · CT.gov ↗
What to watch
Phase 4Nasopharyngeal Cancer RecurrentRecruiting
Est. primary completion 2027-12 · NCT06457503 · CT.gov ↗
What to watch
Phase 1Colorectal Cancer MetastaticNot yet recruiting
Est. primary completion 2027-12-01 · NCT06283134 · CT.gov ↗
What to watch
Phase 2Bladder CancerRecruiting
Est. primary completion 2027-12-08 · NCT07307456 · CT.gov ↗
What to watch
Phase 2Muscle-invasive Bladder Urothelial CarcinomaNot yet recruiting
Est. primary completion 2027-12-10 · NCT07279597 · CT.gov ↗
What to watch
Phase 3Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2027-12-15 · NCT07246330 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-18 · NCT07286942 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2027-12-20 · NCT05869227 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2027-12-25 · NCT07272291 · CT.gov ↗
What to watch
Phase 3Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2027-12-28 · NCT06952621 · CT.gov ↗
What to watch
Phase 1/2Solid Tumor, Sarcoma, Leiomyosarcoma, Dedifferentiated LiposarcomaRecruiting
Est. primary completion 2027-12-29 · NCT06975293 · CT.gov ↗
What to watch
Phase 2Oligometastatic Clear Cell Renal Cell CarcinomaRecruiting
Est. primary completion 2027-12-30 · NCT07744932 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC)Active not recruiting
Est. primary completion 2027-12-30 · NCT07380633 · CT.gov ↗
What to watch
Phase 2Muscle Invasive Bladder Cancer (MIBC)Not yet recruiting
Est. primary completion 2027-12-30 · NCT07201675 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsActive not recruiting
Est. primary completion 2027-12-31 · NCT05502393 · CT.gov ↗
What to watch
Phase 1Malignant TumorsRecruiting
Est. primary completion 2027-12-31 · NCT07004244 · CT.gov ↗
What to watch
Phase 2ER+/HER2- Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT06964906 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck CancerRecruiting
Est. primary completion 2027-12-31 · NCT07214987 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07555860 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Cervical Cancer, Recurrent, MetastaticNot yet recruiting
Est. primary completion 2027-12-31 · NCT07363330 · CT.gov ↗
What to watch
Phase 2Urothelial CarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT07314723 · CT.gov ↗
What to watch
Phase 2Clear Cell RCCRecruiting
Est. primary completion 2027-12-31 · NCT07571551 · CT.gov ↗
What to watch
Phase 2Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell CarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07776717 · CT.gov ↗
What to watch
Phase 2/3Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07653451 · CT.gov ↗
What to watch
Phase 3Renal Cell Carcinoma, NeoadjuvantRecruiting
Est. primary completion 2027-12-31 · NCT05738694 · CT.gov ↗
What to watch
2028 (57)
January 2028 (10)
Phase 1Metastatic Solid Tumor, Advanced Solid TumorRecruiting
Est. primary completion 2028-01 · NCT06657144 · CT.gov ↗
What to watch
Phase 1/2Solid CancerActive not recruiting
Est. primary completion 2028-01-01 · NCT06771622 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-01-01 · NCT07358689 · CT.gov ↗
What to watch
Phase 2Rectal Adenocarcinoma, High-risk Locally Advanced, Short-course Radiotherapy (SCRT), Immunotherapy, FOLFOXRecruiting
Est. primary completion 2028-01-01 · NCT07669220 · CT.gov ↗
What to watch
Phase 2TNBC, Triple Negative Breast CancerRecruiting
Est. primary completion 2028-01-04 · NCT07457359 · CT.gov ↗
What to watch
Phase 2Solid Tumor, Advanced CancerRecruiting
Est. primary completion 2028-01-15 · NCT03810339 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumorNot yet recruiting
Est. primary completion 2028-01-26 · NCT06873854 · CT.gov ↗
What to watch
Phase 2TNBC - Triple-Negative Breast Cancer, PD-L1 PositiveNot yet recruiting
Est. primary completion 2028-01-30 · NCT07244874 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Cancinoma (NPC), Nasopharangeal CancerRecruiting
Est. primary completion 2028-01-30 · NCT07325539 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer ResectableNot yet recruiting
Est. primary completion 2028-01-31 · NCT07469956 · CT.gov ↗
What to watch
February 2028 (5)
Phase 1/2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2028-02 · NCT07258979 · CT.gov ↗
What to watch
Phase 2HR Positive/HER2 Low Breast CancerRecruiting
Est. primary completion 2028-02-01 · NCT07383818 · CT.gov ↗
What to watch
Phase 2Sinonasal Cancer, Paranasal Sinus Neoplasms, Squamous Cell Carcinoma, Sinonasal Undifferentiated Carcinoma …Recruiting
Est. primary completion 2028-02-01 · NCT06940180 · CT.gov ↗
What to watch
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2028-02-19 · NCT06832982 · CT.gov ↗
What to watch
Phase 2Breast CancerNot yet recruiting
Est. primary completion 2028-02-21 · NCT07410234 · CT.gov ↗
What to watch
March 2028 (3)
Phase 1/2Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With ImmunotherapyNot yet recruiting
Est. primary completion 2028-03-01 · NCT07630363 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2028-03-01 · NCT07388836 · CT.gov ↗
What to watch
Phase 1Head & Neck Cancer, Nasopharyngeal Cancinoma (NPC)Recruiting
Est. primary completion 2028-03-30 · NCT07625423 · CT.gov ↗
What to watch
April 2028 (4)
Early phase / not applicableCarcinoma, Renal Cell, Metastatic Renal Cell Carcinoma, Advanced Renal Cell CarcinomaNot yet recruiting
Est. primary completion 2028-04 · NCT07500831 · CT.gov ↗
What to watch
Phase 2Colorectal Cancer, Microsatellite Instability High, Mismatch Repair DeficiencyRecruiting
Est. primary completion 2028-04-01 · NCT06903858 · CT.gov ↗
What to watch
Phase 1Small Cell Carcinoma of LungNot yet recruiting
Est. primary completion 2028-04-28 · NCT07550842 · CT.gov ↗
What to watch
Phase 1Advanced MelanomaRecruiting
Est. primary completion 2028-04-30 · NCT07562841 · CT.gov ↗
What to watch
May 2028 (2)
June 2028 (6)
Phase 1/2Small Cell Lung CancerRecruiting
Est. primary completion 2028-06-01 · NCT07559929 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2028-06-30 · NCT07680582 · CT.gov ↗
What to watch
Phase 2Liver CancerNot yet recruiting
Est. primary completion 2028-06-30 · NCT07685535 · CT.gov ↗
What to watch
Phase 2Bladder Urothelial Carcinoma, Bladder CancerRecruiting
Est. primary completion 2028-06-30 · NCT07717242 · CT.gov ↗
What to watch
Phase 3Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2028-06-30 · NCT07445295 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2028-06-30 · NCT06228079 · CT.gov ↗
What to watch
July 2028 (1)
Phase 4Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-07-01 · NCT07619235 · CT.gov ↗
What to watch
August 2028 (5)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-08-05 · NCT07855965 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-08-05 · NCT06984588 · CT.gov ↗
What to watch
Phase 3Locally Advanced or Metastatic GC and GCJ AdenocarcinomaRecruiting
Est. primary completion 2028-08-17 · NCT07362186 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2028-08-20 · NCT06561763 · CT.gov ↗
What to watch
Phase 2Oral Squamous Cell Carcinoma (OSCC)Not yet recruiting
Est. primary completion 2028-08-31 · NCT07778368 · CT.gov ↗
What to watch
October 2028 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-10-31 · NCT07251582 · CT.gov ↗
What to watch
November 2028 (3)
Phase 3Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2028-11-26 · NCT06712888 · CT.gov ↗
What to watch
Phase 2Toripalimab, Surufatinib, Chemoradiotherapy, Limited-stage Small Cell Lung Cancer (LS-SCLC)Recruiting
Est. primary completion 2028-11-29 · NCT06719700 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-11-30 · NCT06706219 · CT.gov ↗
What to watch
December 2028 (17)
Phase 2Upper Tract Urothelial CarcinomaNot yet recruiting
Est. primary completion 2028-12 · NCT07412171 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-01 · NCT07819578 · CT.gov ↗
What to watch
Phase 1/2Solid TumorNot yet recruiting
Est. primary completion 2028-12-05 · NCT07245901 · CT.gov ↗
What to watch
Phase 1/2Metastatic Microsatellite Stable Colorectal CarcinomaRecruiting
Est. primary completion 2028-12-15 · NCT07281716 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2028-12-25 · NCT06682780 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2028-12-30 · NCT07508761 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12-30 · NCT07039656 · CT.gov ↗
What to watch
Phase 2Melanoma of Skin, Acral Melanoma, Stage II MelanomaRecruiting
Est. primary completion 2028-12-30 · NCT06965231 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT07683832 · CT.gov ↗
What to watch
Phase 1/2Metastatic Colorectal Cancer, Liver MetastasesRecruiting
Est. primary completion 2028-12-31 · NCT07277322 · CT.gov ↗
What to watch
Phase 2TNBC - Triple-Negative Breast CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT07256964 · CT.gov ↗
What to watch
Phase 2Advanced RCCRecruiting
Est. primary completion 2028-12-31 · NCT07611825 · CT.gov ↗
What to watch
Phase 2Dermatofibrosarcoma Protuberans (DFSP)Not yet recruiting
Est. primary completion 2028-12-31 · NCT07646080 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaEnrolling by invitation
Est. primary completion 2028-12-31 · NCT05441475 · CT.gov ↗
What to watch
Phase 2Recurrent Rectal CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT06751394 · CT.gov ↗
What to watch
Phase 3NK/T Cell Lymphoma NosRecruiting
Est. primary completion 2028-12-31 · NCT04365036 · CT.gov ↗
What to watch
Early phase / not applicableCervical Cancer, Chemoradiotherapy, ImmunotherapyRecruiting
Est. primary completion 2028-12-31 · NCT06256224 · CT.gov ↗
What to watch
2029 (24)
January 2029 (5)
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2029-01 · NCT06592599 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-01 · NCT06709274 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2029-01-30 · NCT07677475 · CT.gov ↗
What to watch
Phase 1Solid TumorsNot yet recruiting
Est. primary completion 2029-01-31 · NCT07583953 · CT.gov ↗
What to watch
Phase 3Gastric AdenocarcinomaRecruiting
Est. primary completion 2029-01-31 · NCT07584135 · CT.gov ↗
What to watch
March 2029 (2)
Phase 2Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage IIINot yet recruiting
Est. primary completion 2029-03-01 · NCT06903871 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Cancinoma (NPC)Recruiting
Est. primary completion 2029-03-12 · NCT07362979 · CT.gov ↗
What to watch
April 2029 (2)
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2029-04-20 · NCT06912711 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Locally Advanced Laryngeal Squamous Cell Carcinoma …Recruiting
Est. primary completion 2029-04-30 · NCT07423078 · CT.gov ↗
What to watch
May 2029 (1)
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-05 · NCT07608159 · CT.gov ↗
What to watch
June 2029 (5)
Phase 2Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2029-06-01 · NCT06987123 · CT.gov ↗
What to watch
Phase 2/3Bladder Urothelial Carcinoma, Muscle-invasive Bladder Cancer, Bladder CancerNot yet recruiting
Est. primary completion 2029-06-20 · NCT07756008 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorRecruiting
Est. primary completion 2029-06-30 · NCT06953323 · CT.gov ↗
What to watch
Phase 2Breast CancerRecruiting
Est. primary completion 2029-06-30 · NCT07378306 · CT.gov ↗
What to watch
Phase 2Renal Cell Carcinoma (RCC), AdjuvantActive not recruiting
Est. primary completion 2029-06-30 · NCT07047001 · CT.gov ↗
What to watch
August 2029 (1)
Phase 2Nasopharyngeal Cancinoma (NPC)Not yet recruiting
Est. primary completion 2029-08-14 · NCT07110558 · CT.gov ↗
What to watch
September 2029 (4)
Phase 2Triple Negative Breast Cancer (TNBC)Recruiting
Est. primary completion 2029-09 · NCT06636981 · CT.gov ↗
What to watch
Phase 2Localized Colon Carcinoma, Stage IIB Colon Cancer AJCC v8, Stage IIC Colon Cancer AJCC v8, Stage III Colon Cancer AJCC v8Recruiting
Est. primary completion 2029-09-30 · NCT07140679 · CT.gov ↗
What to watch
Phase 3Cervical Cancer MetastaticNot yet recruiting
Est. primary completion 2029-09-30 · NCT07392060 · CT.gov ↗
What to watch
Phase 3Squamous Cell Carcinoma of Head and NeckNot yet recruiting
Est. primary completion 2029-09-30 · NCT06647563 · CT.gov ↗
What to watch
October 2029 (1)
Phase 3Esophageal CancerNot yet recruiting
Est. primary completion 2029-10-01 · NCT07332221 · CT.gov ↗
What to watch
November 2029 (1)
Phase 1/2Solid TumorRecruiting
Est. primary completion 2029-11-07 · NCT07392736 · CT.gov ↗
What to watch
2030 (7)
January 2030 (1)
Phase 2SCLC, Extensive Stage, Bayesian, Metronomic ChemotherapyNot yet recruiting
Est. primary completion 2030-01-01 · NCT07698054 · CT.gov ↗
What to watch
February 2030 (2)
June 2030 (1)
Phase 2/3Urinary Bladder NeoplasmsNot yet recruiting
Est. primary completion 2030-06-30 · NCT07608224 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2Postoperative Incidental Small Cell Lung Cancer, Toripalimab Adjuvant Therapy EvaluationNot yet recruiting
Est. primary completion 2030-07 · NCT07097948 · CT.gov ↗
What to watch
September 2030 (1)
Phase 2Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer RecurrentNot yet recruiting
Est. primary completion 2030-09-01 · NCT06648200 · CT.gov ↗
What to watch
October 2030 (1)
Phase 2Head and Neck Cancer, Squamous Cell Carcinoma, Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer …Recruiting
Est. primary completion 2030-10-01 · NCT07209189 · CT.gov ↗
What to watch
2031 (3)
March 2031 (1)
Phase 2Muscle Invasive Bladder Cancer (MIBC)Not yet recruiting
Est. primary completion 2031-03-31 · NCT07474064 · CT.gov ↗
What to watch
September 2031 (1)
Phase 3Nasopharyngeal Cancinoma (NPC)Recruiting
Est. primary completion 2031-09 · NCT07154069 · CT.gov ↗
What to watch
December 2031 (1)
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2031-12-31 · NCT07340515 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.